These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28181429)

  • 1. Fluconazole-containing agar Sabouraud dextrose plates are not useful when screening for susceptibility in Candida albicans.
    Bordallo-Cardona MA; Marcos-Zambrano LJ; Gómez G de la Pedrosa E; Escribano P; Bouza E; Guinea J; Cantón R
    Rev Esp Quimioter; 2017 Apr; 30(2):127-130. PubMed ID: 28181429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scope and frequency of fluconazole trailing assessed using EUCAST in invasive Candida spp. isolates.
    Marcos-Zambrano LJ; Escribano P; Sánchez-Carrillo C; Bouza E; Guinea J
    Med Mycol; 2016 Oct; 54(7):733-9. PubMed ID: 27161788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole].
    Yücesoy M; Marol S
    Mikrobiyol Bul; 2002; 36(3-4):317-22. PubMed ID: 12838666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disk diffusion method for fluconazole susceptibility testing of Candida albicans strains.
    Yücesoy M; Guldaş NS; Yuluğ N
    J Chemother; 2001 Apr; 13(2):161-6. PubMed ID: 11330363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Etest Performed Directly on Blood Culture Bottles Is a Reliable Tool for Detection of Fluconazole-Resistant Candida albicans Isolates.
    Escribano P; Marcos-Zambrano LJ; Gómez A; Sánchez C; Martínez-Jiménez MC; Bouza E; Guinea J
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of different susceptibility testing methods and media on determination of the relevant fluconazole minimum inhibitory concentrations for heavy trailing Candida isolates with low-high phenotype.
    Alp S; Sancak B; Hascelik G; Arikan S
    Mycoses; 2010 Nov; 53(6):475-80. PubMed ID: 19563491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans.
    Arthington-Skaggs BA; Jradi H; Desai T; Morrison CJ
    J Clin Microbiol; 1999 Oct; 37(10):3332-7. PubMed ID: 10488201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
    Tan GL; Peterson EM
    J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study.
    Lee MK; Kim HR; Kang JO; Kim MN; Kim EC; Kim JS; Kim JJ; Park YJ; Song W; Shin JH; Lee KM; Lee NY; Lee M; Lee WG; Lee CK; Lee HJ; Chang CL; Choi TY
    Mycoses; 2007 Mar; 50(2):148-9. PubMed ID: 17305780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of semisolid agar screening tests for determining fluconazole and amphotericin B susceptibilities of Candida strains by using three different media.
    Esen N; Yücesoy M; Yuluğ N
    J Chemother; 2003 Feb; 15(1):37-42. PubMed ID: 12678412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans.
    Patterson TF; Kirkpatrick WR; Revankar SG; McAtee RK; Fothergill AW; McCarthy DI; Rinaldi MG
    J Clin Microbiol; 1996 Dec; 34(12):3237-9. PubMed ID: 8940483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antifungal activity of the berberine and its synergism with fluconazole.
    Iwazaki RS; Endo EH; Ueda-Nakamura T; Nakamura CV; Garcia LB; Filho BP
    Antonie Van Leeuwenhoek; 2010 Feb; 97(2):201-5. PubMed ID: 19882381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fluconazole on agar invasion by Candida albicans.
    Kontoyiannis DP; Tarrand J; Prince R; Samonis G; Rolston KVR
    J Med Microbiol; 2001 Jan; 50(1):78-82. PubMed ID: 11192509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the fluconazole trailing effect on the persistence of Candida albicans bloodstream infection when treated with fluconazole.
    Lin SY; Huang HY; Chang LL; Wang YL; Chen TC; Chang K; Tu HP; Lu PL
    Clin Microbiol Infect; 2024 Jul; 30(7):945-950. PubMed ID: 38527614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing the trailing endpoint observed in Candida albicans susceptibility testing using the CLSI procedure.
    Coenye T; De Vos M; Vandenbosch D; Nelis H
    Clin Microbiol Infect; 2008 May; 14(5):495-7. PubMed ID: 18341604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility profile of vaginal isolates of Candida albicans prior to and following fluconazole introduction - impact of two decades.
    Bulik CC; Sobel JD; Nailor MD
    Mycoses; 2011 Jan; 54(1):34-8. PubMed ID: 19563489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
    Lee SC; Lo HJ; Fung CP; Lee N; See LC
    J Microbiol Immunol Infect; 2009 Apr; 42(2):148-53. PubMed ID: 19597647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance genes and trailing growth in Candida albicans isolates.
    Lee MK; Williams LE; Warnock DW; Arthington-Skaggs BA
    J Antimicrob Chemother; 2004 Feb; 53(2):217-24. PubMed ID: 14688046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.